Pharma Tips

Ranbaxy gets FDA approval to sell generic Diovan tablets in US

By: Pharma News | Views: 1554 | Date: 27-Jun-2014

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US market with 180-days of marketing exclusivity.

Ranbaxy gets FDA approval to sell generic Diovan tablets in US



FDA approves Ranbaxy's generic version of Novartis's Diovan

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US market with 180-days of marketing exclusivity.

Ohm Laboratories Inc, a wholly-owned subsidiary of Ranbaxy has received approval from the US Food and Drug Administration (USFDA) for manufacturing and marketing Valsartan tablets in strengths of 40 mg, 80 mg, 160 mg, and 320 mg on an exclusive basis, Ranbaxy Laboratories said in a statement.

"The Office of Generic Drugs, USFDA, has determined the Ohm formulation to be bio-equivalent and have the same therapeutic effect as that of the branded drug Diovan," it added.

According to IMS-MAT sales data for April 2014, the total annual market sales for Diovan stood at $2.19 billion.

"Ohm is pleased to announce this first-to-file FDA approval for Valsartan tablets, which will be introduced to all classes of trade, with 180-days marketing exclusivity, as soon as sufficient supplies are manufactured to meet the needs of the market," Ohm Laboratories Vice President, Sales and Distribution, North America, Bill Winter said.

Valsartan will be manufactured at Ohm facilities located in New Brunswick, New Jersey, he added.

North Brunswick-based Ohm Laboratories is engaged in the manufacturing, sale and distribution of generic, branded and over-the-counter products in the US healthcare system.

Ranbaxy's shares were trading 5.78 per cent up at Rs 499 apiece on the BSE in morning trade.


Previous Page Next Page

People Searching On This Page:

Related Pages


New & Generic Drug Approvals by US FDA -2014

New & Generic Drug Approvals by US FDA -2014

News | FDA
Date:
23-Sep-2014  Views: 2306

...
Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets

Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets

News | FDA
Date:
14-Aug-2014  Views: 1577

Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidne ...
Strides gets FDA approval to market skin disease drug in US

Strides gets FDA approval to market skin disease drug in US

News | FDA
Date:
05-Jul-2014  Views: 1172

Strides Arcolab has received regulatory approval to market a skin disease drug in the US.The US Food and Drug Administration (FDA) has allowed the com ...
Glenmark gets USFDA nod for alcohol abstinence drug

Glenmark gets USFDA nod for alcohol abstinence drug

News | FDA
Date:
14-Aug-2013  Views: 8330

Glenmark Pharmaceuticals today said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed R ...
US FDA trusts Indian GMP

US FDA trusts Indian GMP

News | FDA
Date:
07-Aug-2013  Views: 1406

The United States Food and Drug Administration (USFDA), which is considered to be the most stringent authority Indian drug makers, have been following ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

7  + 8 =     
Comments

Google : 54 times | Yahoo : 48 times | Bing : 25 times |